Indeed, our present results revealed that CDDP treatment increases HIF-1α protein level, its recruitment onto the putative HIF-1α-binding site of miR-424 and enhances its transcriptional activity in bladder cancer cells under normoxia. Here, HIF1A is linked to urinary bladder cancer.